In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Celestica, Inc’s stock clocked out at $158.83, down -1.29% from its previous closing price of $160.9. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 3.54 million shares were traded. CLS stock price reached its highest trading level at $163.05 during the session, while it also had its lowest trading level at $153.0.
Ratios:
To gain a deeper understanding of CLS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 60.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.59. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on February 21, 2025, initiated with a Overweight rating and assigned the stock a target price of $166.
CIBC Upgraded its Neutral to Sector Outperform on January 31, 2025, while the target price for the stock was maintained at $150.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 30 ’25 when Agrawal Alok K. bought 3,672 shares for $119.47 per share.
Laurette Koellner bought 100,000 shares of CLS for $8,269,000 on Mar 31 ’25. On Mar 19 ’25, another insider, Laurette T Koellner, who serves as the Director of the company, bought 151,717 shares for $91.92 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 18264178688 and an Enterprise Value of 18721298432. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.38, and their Forward P/E ratio for the next fiscal year is 25.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 11.79. Its current Enterprise Value per Revenue stands at 1.856 whereas that against EBITDA is 24.298.
Stock Price History:
The Beta on a monthly basis for CLS is 1.79, which has changed by 1.6739056 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $163.95, while it has fallen to a 52-week low of $40.25. The 50-Day Moving Average of the stock is 28.91%, while the 200-Day Moving Average is calculated to be 63.67%.
Shares Statistics:
It appears that CLS traded 3.80M shares on average per day over the past three months and 3445900 shares per day over the past ten days. A total of 115.60M shares are outstanding, with a floating share count of 114.38M. Insiders hold about 0.53% of the company’s shares, while institutions hold 76.99% stake in the company. Shares short for CLS as of 1749772800 were 4053526 with a Short Ratio of 1.07, compared to 1747267200 on 3936460. Therefore, it implies a Short% of Shares Outstanding of 4053526 and a Short% of Float of 3.54.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 10.0 analysts are dedicated to thoroughly evaluating and rating the performance of Celestica, Inc (CLS) in the stock market.The consensus estimate for the next quarter is $1.28, with high estimates of $1.31 and low estimates of $1.26.
Analysts are recommending an EPS of between $5.15 and $4.98 for the fiscal current year, implying an average EPS of $5.03. EPS for the following year is $6.12, with 12.0 analysts recommending between $6.65 and $5.54.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $2.65B. It ranges from a high estimate of $2.66B to a low estimate of $2.64B. As of the current estimate, Celestica, Inc’s year-ago sales were $2.39BFor the next quarter, 10 analysts are estimating revenue of $2.76B. There is a high estimate of $2.79B for the next quarter, whereas the lowest estimate is $2.72B.
A total of 12 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $11.1B, while the lowest revenue estimate was $10.85B, resulting in an average revenue estimate of $10.95B. In the same quarter a year ago, actual revenue was $9.65BBased on 12 analysts’ estimates, the company’s revenue will be $12.83B in the next fiscal year. The high estimate is $13.49B and the low estimate is $12.27B.
